Tigilanol Tilglate: A new treatment option for mast cell tumors in dogs.

---

Virbac is proud to introduce STELFONTA®(tigilanol tiglate injection). STELFONTA® is an FDA approved, intratumoral injection indicated for use in dogs for the local treatment of: Non-metastatic cutaneous mast cell tumors anywhere on the body Non-metastatic subcutaneous mast cell tumors located at or distal to the elbow or hock STELFONTA® contains the active ingredient tigilanol tiglate, which is in a class of diterpene esters called epoxy-tigilanes.Tigilanol tiglate is extracted from the seed of the Fontainea picrosperma (blushwood) tree, which originates in the Australian tropical rainforest. With this new intratumoral treatment, Virbac once again demonstrates its commitment and ability to offer unique solutions for the advancement of veterinary medicine. Please join us to learn more about this exciting new option for mast cell tumor treatment in dogs.

This is a live event only and will not be recorded. This program is approved for 1.5 hours of continuing education credit in jurisdictions which recognize RACE. You must attend the full presentation to receive CE credit.

IMPORTANT SAFETY INFORMATION Accidental self-injection of STELFONTA®(tigilanol tiglate injection) may cause severe wound formation. To decrease the risk of accidental self-injection, sedation of the dog may be necessary. In dogs, do not inject STELFONTA® into subcutaneous mast cell tumors located above the elbow or hock. Formation of wounds, possibly extensive, is an intended and likely response to treatment with STELFONTA® along with associated swelling, bruising and pain; these wounds are expedted to heal. Appropriate pre- and post-treatment medications must be given, including a corticosteroid plus blocking agents for both H1 and H2 receptors, in order to decrease the potential for severe systemic adverse reactions, including death, from mast cell degranulation. For full prescribing information, contact VIRBAC at 1-800-338-3659 or visit https://vet-us.virbac.com/stelfonta.

Speaker: Dr. Scott Weinman, DVM, MBA

Scott Weinman was raised on a family farm in Minnesota.  From a very early age, he dreamed of becoming a veterinarian. After completing degrees in Biology and Chemistry from Concordia College in Moorhead, MN, he attended Iowa State University’s College of Veterinary Medicine where he obtained his Doctor of Veterinary Medicine Degree. While in practice, he returned to Seattle University-Alber’s School of Business and Economics to earn his MBA in Operations Management.  Dr. Weinman completed a year-long Fellowship in Shelter Medicine (focus on infectious disease) in 2016 at UC Davis.

His veterinary career has encompassed general and emergency practice, managing veterinary practices, serving on the board of a multi-state practice network, working as a corporate trainer, providing relief veterinary services, and business consulting. Also, he has spent over a decade as a Field Based Technical Services Veterinarian, speaking on a variety of topics from Heartworm disease, Osteoarthritis, Pain Management, Canine & Feline Heart Disease, Atopic Dermatitis, Oncology, Wound Closure & Management, Infectious Disease and Vaccinology, and management topics such as Medical Adherence, Teambuilding and Leadership, and Marketing. Prior to joining Virbac, Dr. Weinman was an acute care veterinarian at a busy 24 hour emergency practice in the Portland area.

Dr. Weinman currently resides in Davis, CA where he lives with his partner, a labradoodle named “Daisy,” and a tuxedo cat named “Pinot Noir.”  He enjoys travel, outdoor activities, and is an amateur mixologist and chef.